MyAverix Finance
AU · Healthcare
Neuroscientific Biopharmaceuticals Ltd (NSB)
Biotechnology
Neuroscientific Biopharmaceuticals Ltd (NSB) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NSB
Neuroscientific Biopharmaceuticals Ltd (NSB) — FAQ
What is NSB's P/E ratio?
The price-to-earnings (P/E) ratio for Neuroscientific Biopharmaceuticals Ltd (NSB) is 18.00 (data as of 2026-03-23).
Does Neuroscientific Biopharmaceuticals Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Neuroscientific Biopharmaceuticals Ltd (NSB). Check the MyAverix Finance app for the latest dividend data.
What sector is Neuroscientific Biopharmaceuticals Ltd in?
Neuroscientific Biopharmaceuticals Ltd (NSB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NSB listed on?
NSB is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.